Physician profile
John P Rodriguez
NPI 1578875092
$4,316.82
in general payments reported to CMS, 2019-2025
18 companies · $180 in 2025
The $180 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,097 · 2020: $1,213 · 2021: $1,466 · 2022: $115 · 2023: $153 · 2024: $92.39 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $425.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $425.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medinc of Texas | $3,169.72 | 2019-2021 | |
| Acumed LLC | $246.90 | 2019 | |
| Miach Orthopaedics, INC. | $186.73 | 2021 | |
| Ucb, INC. | $121.70 | 2021-2023 | Cimzia |
| Amgen INC. | $111.02 | 2020-2023 | Enbrel |
| Abbvie INC. | $102.86 | 2025 | |
| Core Surgical Group | $72.29 | 2024-2025 | |
| Aurinia Pharma U.S., INC. | $56.31 | 2022-2023 | Lupkynis |
| Stryker Corporation | $48.74 | 2024 | 1788, System 9 Cd Nxt, Tornier Perform Reversed Glenoid |
| Radius Health, INC. | $45.74 | 2019-2024 | Tymlos |
| Arthrex, INC. | $33.64 | 2025 | |
| Mallinckrodt Hospital Products INC. | $29.36 | 2023 | Acthar |
| Horizon Therapeutics Plc | $18.66 | 2019 | |
| Abbott Laboratories | $17.50 | 2023 | Proclaim |
| Organon LLC | $15.45 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $14.83 | 2019 | |
| Alexion Pharmaceuticals, INC. | $14.02 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $11.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Rodriguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.